QUEST DIAGNOSTICS INCORPORATED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 134.3 USD | -0.86% |
|
+4.53% | -2.63% |
| Apr. 25 | Labcorp beats quarterly estimates on strong testing demand | RE |
| Apr. 24 | Jefferies Adjusts Price Target on Quest Diagnostics to $160 From $155 | MT |
Presenter SpeechErin Wilson Wright (Analysts)Okay. So hi, everyone. Thank you for joining us t...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Quest Diagnostics is the world's leading provider of diagnostics testing and information service for patients and health professionals. Net sales break down by activity as follows:
- testing and diagnostic services (97.3%): routine clinical testing, gene-based testing and advanced diagnostic and anatomica pathology diagnostic services;
- other (2.7%).
Calendar
2024-07-23
- Q2 2024 Earnings Release (Projected)
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
134.3
USD
Average target price
146
USD
Spread / Average Target
+8.77%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -2.63% | 15.04B | |
| -14.92% | 84.87B | |
| +13.30% | 83.08B | |
| +10.92% | 29.4B | |
| -12.71% | 16.72B | |
| -3.06% | 16.4B | |
| -3.97% | 11.88B | |
| -1.42% | 11.88B | |
| -31.75% | 11.86B | |
| +27.44% | 11.64B |
- Stock Market
- Equities
- DGX Stock
- News Quest Diagnostics Incorporated
- Transcript : Quest Diagnostics Incorporated Presents at Morgan Stanley 20th Annual Global Healthcare Conference, Sep-13-2022 04
